(Total Views: 599)
Posted On: 07/20/2022 4:01:37 PM
Post# of 148878
I think Pfizer and GSK compete on drug innovation and they merged on the healthcare portion of their companies, I think. But I know they compete on drug innovation.
This is the nice position for Leronlimab to be in, any one of these competing companies could see LL as a way to scoop their competition in a variety of indications.
This is the nice position for Leronlimab to be in, any one of these competing companies could see LL as a way to scoop their competition in a variety of indications.
(2)
(0)Scroll down for more posts ▼
